Singh, A. K., Gupta, R., & Misra, A. (2020). Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.). Diabetes Metab Syndr.
Styl ChicagoSingh, Awadhesh Kumar, Ritesh Gupta, a Anoop Misra. "Reply to the Letter of Mahajan and Gaur in Response to the Article: Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies With Renin Angiotensin System Blockers (Singh Et al.)." Diabetes Metab Syndr 2020.
Citace podle MLASingh, Awadhesh Kumar, Ritesh Gupta, a Anoop Misra. "Reply to the Letter of Mahajan and Gaur in Response to the Article: Comorbidities in COVID-19: Outcomes in Hypertensive Cohort and Controversies With Renin Angiotensin System Blockers (Singh Et al.)." Diabetes Metab Syndr 2020.